The Veterinary Drugs Industry includes broad-spectrum parasiticides, specialized monoclonal antibody therapies for companion animals, water-soluble antimicrobial premixes, and next-generation preventive vaccines built to satisfy stringent regulatory benchmarks.
The global Veterinary Drugs Market Size was valued at US$ 32.67 Billion in 2025 and is projected to reach US$ 56.79 Billion by 2033, growing at a CAGR of 7.16% during 2026–2033.